TEZSPIRE Approved for Self-Administration in the US With a New Pre-Filled Pen

The Asthma and Allergy Foundation of America (AAFA) is sharing this press release from AstraZeneca to bring you the latest research news. [PRESS RELEASE] TEZSPIRE approved for self-administration in the US with a new pre-filled pen First and only respiratory biologic without phenotype or biomarker limitations that offers the choice of administration at home or in a doctor’s office AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) has been approved in the US for self-administration in a…

Lesen Sie weiter auf: TEZSPIRE Approved for Self-Administration in the US With a New Pre-Filled Pen
Quelle: Asthma and Allergy Foundation of America
Titelbild/Grafik by Asthma and Allergy Foundation of America (AAFA)

Kommentare und Fragen

Möchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!

Weiteres von Asthma and Allergy Foundation of America

• 2023 Allergy Capitals™ Report: Where Does Your City Rank?
• Learn How to Better Manage CSU (Webinar)
• Ask the EPA to Strengthen the Soot Pollution Standards
• Darren Riley: Working Toward Equitable Air Quality
• Asthma Medicines Can Affect Your Oral Health
• Asthma and the “Tripledemic” (Flu, COVID-19, and RSV) - Video
• Asthma and Allergy Research Updates – February 2023
• Families Managing Asthma in Four U.S. Cities Receive Products to Help Them Make Their Homes Healthier
• Linda Nozart: Guiding a Community Toward Better Asthma Control
• Recall Alert: Skippack SARS-CoV-2 Antigen Rapid Test Kit